Benzamide, N-[4-[3,5-bis(trifluoromethyl)phenoxy]phenyl]-2-fluoro-6-iodo- manufacturers
- CU-115
-
- $32.00
-
2026-07-27
- CAS:2471982-20-2
- Purity: 99.96%
- Supply Ability: 10g
|
| | Benzamide, N-[4-[3,5-bis(trifluoromethyl)phenoxy]phenyl]-2-fluoro-6-iodo- Basic information |
| | Benzamide, N-[4-[3,5-bis(trifluoromethyl)phenoxy]phenyl]-2-fluoro-6-iodo- Chemical Properties |
| Boiling point | 427.3±45.0 °C(Predicted) | | density | 1.713±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMF: 10mg/mL,DMSO: 10mg/mL,DMSO:PBS (pH 7.2) (1:5): 0.15mg/mL,Ethanol: 0.25mg/mL | | form | A crystalline solid | | pka | 11.28±0.70(Predicted) | | color | White to off-white |
| | Benzamide, N-[4-[3,5-bis(trifluoromethyl)phenoxy]phenyl]-2-fluoro-6-iodo- Usage And Synthesis |
| Uses | CU-115 is a potent TLR8 antagonist (IC50=1.04 μM), and shows selective for TLR8 over TLR7 (IC50=>50 μM). CU-115 decreases TNF-α and IL-1β production activated by R-848 in THP-1 cells[1]. | | IC 50 | TLR8: 1.04 μM (IC50); TLR7: 50 μM (IC50) | | References | [1] Rosaura Padilla-Salinas, et al. Discovery of Novel Small Molecule Dual Inhibitors Targeting Toll-Like Receptors 7 and 8. J Med Chem. 2019 Nov 27;62(22):10221-10244. DOI:10.1021/acs.jmedchem.9b01201 |
| | Benzamide, N-[4-[3,5-bis(trifluoromethyl)phenoxy]phenyl]-2-fluoro-6-iodo- Preparation Products And Raw materials |
|